OSCR(OSCR)
OSCR
Q3 2026 EPS Estimate
$0.34
Aug 5, 2026 · Reports before open
Revenue Estimate
$4.73B
FY2026E EPS$1.04
FY2027E EPS$1.45
Analyst Sentiment
Wall St. Consensus
Hold11 analysts·Moderate coverage
52
Score
3 Buy (27%)6 Hold (55%)2 Sell (18%)
Rating Breakdown
Strong Buy
00%
Buy
327%
Hold
655%
Sell
218%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$16.00
-49.8%
Consensus
$20.00
-37.3%
Bull
$35.00
+9.7%
12-Month Target Range11 analysts
$16.00$20.00$35.00
Current $31.90Consensus
Current Price
$31.90
Above Consensus
$11.90
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev+7.36%
EPS+38.70%
FY2028
Rev+11.55%
EPS+48.14%
FY2029
Rev+14.08%
EPS+22.29%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $18.53B | $19.89B | $22.19B | $25.31B | $28.23B |
| Low | $18.34B | $19.63B | $22.12B | $23.24B | $25.92B |
| High | $18.73B | $20.16B | $22.25B | $26.23B | $29.25B |
| EBITDA Avg | $-1.80B | $-1.93B | $-2.15B | $-2.46B | $-2.74B |
| Low | $-1.82B | $-1.96B | $-2.16B | $-2.55B | $-2.84B |
| High | $-1.78B | $-1.91B | $-2.15B | $-2.26B | $-2.52B |
| EBIT Avg | $-1.88B | $-2.02B | $-2.25B | $-2.57B | $-2.87B |
| Low | $-1.90B | $-2.05B | $-2.26B | $-2.66B | $-2.97B |
| High | $-1.86B | $-1.99B | $-2.25B | $-2.36B | $-2.63B |
| Net Income Avg | $384M | $546M | $562M | $687M | $740M |
| Low | $-210M | $14M | $505M | $614M | $661M |
| High | $664M | $690M | $619M | $720M | $775M |
| EPS Avg | $1.04 | $1.45 | $2.14 | $2.62 | $2.82 |
| Low | $-0.80 | $0.05 | $1.93 | $2.34 | $2.52 |
| High | $2.53 | $2.63 | $2.36 | $2.74 | $2.95 |
| Analysts (Rev / EPS) | 7 / 6 | 7 / 6 | 6 / 4 | 5 / 2 | 3 / 2 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $4.65B | $4.47B | $5.12B | $5.17B | $5.07B | $4.87B | $5.84B | $5.93B |
| Low | $4.56B | $4.25B | $4.86B | $4.91B | $4.81B | $4.63B | $5.55B | $5.63B |
| High | $4.74B | $4.63B | $5.30B | $5.35B | $5.24B | $5.04B | $6.04B | $6.13B |
| EBITDA Avg | $-451M | $-434M | $-497M | $-502M | $-492M | $-473M | $-567M | $-576M |
| Low | $-460M | $-449M | $-514M | $-519M | $-509M | $-490M | $-587M | $-596M |
| High | $-443M | $-412M | $-472M | $-476M | $-467M | $-449M | $-539M | $-547M |
| EBIT Avg | $-472M | $-454M | $-520M | $-525M | $-515M | $-495M | $-594M | $-602M |
| Low | $-481M | $-470M | $-538M | $-543M | $-533M | $-512M | $-614M | $-623M |
| High | $-463M | $-431M | $-494M | $-498M | $-489M | $-470M | $-564M | $-572M |
| Net Income Avg | $-86M | $-437M | $690M | $173M | $-36M | $-398M | $719M | $224M |
| Low | $-116M | $-456M | $644M | $161M | $-38M | $-416M | $671M | $209M |
| High | $-53M | $-408M | $721M | $180M | $-34M | $-371M | $751M | $234M |
| EPS Avg | $-0.26 | $-1.32 | $2.09 | $0.52 | $-0.11 | $-1.21 | $2.18 | $0.68 |
| Low | $-0.35 | $-1.38 | $1.95 | $0.49 | $-0.11 | $-1.26 | $2.04 | $0.64 |
| High | $-0.16 | $-1.24 | $2.19 | $0.55 | $-0.10 | $-1.13 | $2.28 | $0.71 |
| Analysts (Rev / EPS) | 5 / 6 | 2 / 4 | 2 / 2 | 2 / 2 | 2 / 2 | 2 / 2 | 1 / 3 | 1 / 3 |